HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait

J Thromb Haemost. 2005 Jul;3(7):1467-71. doi: 10.1111/j.1538-7836.2005.01326.x.

Abstract

Background: Venous thromboembolism (VTE) occurs due to a number of hereditary and acquired disorders of hemostasis. A recently identified polymorphism in factor V gene (A4070G; named HR2) has been reported to be a possible risk factor for the development of VTE, with a high prevalence of 9.5%-15.2% in patients of different ethnic groups in different parts of the world. However, the prevalence of HR2 has not yet been tested in VTE patients of Arab ethnicity.

Objectives: To study the prevalence and possible risk of HR2 haplotype in Arabs.

Patients/methods: Exactly 188 VTE patients and 100 healthy subjects, all being of Arab ethnicity, were examined for HR2 using Polymerase chain reaction, restriction fragment length polymorphism and agarose gel electrophoresis.

Results: Data showed that 31 patients and seven healthy subjects had HR2 haplotype, with a prevalence of 16.5% and 7%, respectively. Furthermore, 43 patients (22.9%) had more than one risk factor for VTE.

Conclusions: The prevalence of HR2 in Arabs is quite high, with a 2.62-fold greater risk of developing VTE. Moreover, coexistence of two or more genetic/acquired defects of VTE is quite common in Arab patients.

MeSH terms

  • Arabs
  • Case-Control Studies
  • Electrophoresis, Agar Gel
  • Factor V / genetics*
  • Female
  • Haplotypes
  • Heterozygote
  • Humans
  • Kuwait
  • Male
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Risk
  • Risk Factors
  • Venous Thrombosis / epidemiology*
  • Venous Thrombosis / genetics*

Substances

  • Factor V